Document ID: chunk:federal_register_of_legislation:F2021C00070:reg:3:p1
Version: federal_register_of_legislation:F2021C00070
Segment Type: reg
Provision Reference: reg 3 (pt 1/2)
Character Range: 6390–9264

3  Definitions
  In this instrument:
Act means the National Health Act 1953.
agreed purchase quantity, of an ingredient of an extemporaneously‑prepared pharmaceutical benefit, means the agreed purchase quantity of the ingredient referred to in the determination in force under paragraph 98B(1)(a) of the Act.
approved ex‑manufacturer price has the same meaning as in Part VII of the Act.
approved hospital authority has the same meaning as in Part VII of the Act.
basic wholesale price, in relation to an ingredient of an extemporaneously‑prepared pharmaceutical benefit, is the basic wholesale price of the ingredient referred to in the determination in force under paragraph 98B(1)(a) of the Act.
brand has the same meaning as in Part VII of the Act.
broken quantity, in relation to a ready‑prepared pharmaceutical benefit, means a quantity of the benefit, which is less than a pack quantity.
calculation day means the 16th day of a calendar month or, if the 16th day is not a business day, the next business day.
calculation period, for a calculation day, means the period commencing 4 weeks before the calculation day and ending on the calculation day.
container price, for an extemporaneously‑prepared pharmaceutical benefit, means the price for a container for an extemporaneously‑prepared pharmaceutical benefit calculated in accordance with the determination in force under paragraph 98B(1)(a) of the Act.
determined quantity, of a listed brand of a pharmaceutical item, has the same meaning as in Part VII of the Act.
dispensed price:
 (a) for the supply of a ready‑prepared pharmaceutical benefit: see Part 3; and
 (b) for the supply of an extemporaneously‑prepared pharmaceutical benefit: see Part 4.
exceptional benefit means an extemporaneously‑prepared pharmaceutical benefit that is not a standard formula preparation and for which the dispensed price calculated under Division 1 of Part 4 (excluding the container price) is at least twice the dispensed price calculated under Division 2 of Part 4 (excluding the container price).
extemporaneously‑prepared pharmaceutical benefit means a pharmaceutical benefit that is not a ready‑prepared pharmaceutical benefit.
listed brand has the same meaning as in Part VII of the Act.
maximum quantity, of a brand of a pharmaceutical item, means a quantity or number of units of the pharmaceutical item determined under paragraph 85A(2)(a) of the Act in relation to that brand of pharmaceutical item.
pack quantity has the same meaning as in Part VII of the Act.
patient co‑payment, for a pharmaceutical benefit, means the charge, if any,  that may be made under subsection 87(2) of the Act, to the person to whom the benefit is supplied, by an approved pharmacist or an approved medical practitioner.
pharmaceutical benefit has the same meaning as in Part VII of the Act.
pharmaceutical item has the same meaning as in